Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc has demonstrated a positive financial trajectory, with total revenue per Accountable Healthcare Service Client (AHSC) reaching $26,622, reflecting a year-over-year increase of 5.6% and driven by client expansion across its solution areas. The company's patient payment volumes reached $1.181 billion in the third quarter of FY26, marking a robust 9.3% year-over-year growth, which indicates strong demand and operational effectiveness. Additionally, Phreesia has raised its FY26 adjusted EBITDA guidance to a range of $99 million to $101 million, representing a remarkable 172% year-over-year growth, which positions the company considerably ahead of consensus estimates and signals continued operational strength moving into FY27.

Phreesia Inc. is facing a negative outlook due to declining growth metrics, with management's guidance for FY26 indicating an expected organic growth rate of approximately 13%, a decrease from 18% in FY25, largely driven by a focus on expanding within the existing customer base. Additionally, the company's payment facilitator take rate has slightly decreased from 2.8% to 2.7%, which may indicate reduced profitability from transaction volumes, even as payment facilitator volumes remain stable at 85%. Furthermore, the revenue results for 3Q26 of $120.3 million were marginally below estimates, coupled with concerns over potential impacts on patient visit volumes from a resurgence of COVID-19, which could further affect top-line performance.